AIM: Chemoradiotherapy has great potential to downstage rectal cancer. Response assessment has been investigated in locally advanced rectal cancer, but not in early stage rectal cancer. The aim is to characterize the diagnostic accuracy of endoscopy performed by surgical endoscopists compared to (diffusion-weighted) MRI only and a multimodal approach combining (diffusion-weighted) MRI and endoscopic information both analysed by an abdominal radiologist for response assessment in early rectal cancer after neoadjuvant chemoradiotherapy.MATERIALS AND METHODS: Patients treated with neoadjuvant chemoradiotherapy for early distal rectal cancer (cT1-3N0) followed by transanal endoscopic microsurgery were included. Three separate re-assessment grou...
BACKGROUND: The response to chemoradiotherapy (CRT) for rectal cancer can be assessed by clinical ex...
AbstractBackgroundRectal cancer is one of the most common tumors in industrialized countries and one...
The assessment of tumor response, after neoadjuvant radiochemotherapy (nCRT), allows stratifying the...
Accurate tumor response determination remains inconclusive after preoperative chemoradiation therapy...
Background: It is challenging to restage rectal cancer at MRI, in patients who have had neoadjuvant ...
Background: Rectal cancer is one of the most common tumors in industrialized countries and one of th...
Background Response to neoadjuvant chemoradiotherapy (CRT) of rectal cancer is variable. Accurate im...
Abstract Background Response to neoadjuvant chemoradiotherapy (CRT) of rectal cancer is variable. Ac...
PURPOSE: In 10-24% of patients with rectal cancer who are treated with neoadjuvant chemoradiation, n...
Guidelines recommend MRI as part of the staging work-up of patients with rectal cancer because it ca...
Objective and Background: Watch-and-wait approach in rectal cancer relies on the identification of a...
Background: Response to neoadjuvant chemoradiotherapy (CRT) of rectal cancer is variable. Accurate i...
To determine retrospectively the additional value of DWI-MRI toT2-MRI for predicting complete respon...
Background:The National Accreditation Program for Rectal Cancer recommends a pelvic MRI to assess th...
BACKGROUND: The response to chemoradiotherapy (CRT) for rectal cancer can be assessed by clinical ex...
AbstractBackgroundRectal cancer is one of the most common tumors in industrialized countries and one...
The assessment of tumor response, after neoadjuvant radiochemotherapy (nCRT), allows stratifying the...
Accurate tumor response determination remains inconclusive after preoperative chemoradiation therapy...
Background: It is challenging to restage rectal cancer at MRI, in patients who have had neoadjuvant ...
Background: Rectal cancer is one of the most common tumors in industrialized countries and one of th...
Background Response to neoadjuvant chemoradiotherapy (CRT) of rectal cancer is variable. Accurate im...
Abstract Background Response to neoadjuvant chemoradiotherapy (CRT) of rectal cancer is variable. Ac...
PURPOSE: In 10-24% of patients with rectal cancer who are treated with neoadjuvant chemoradiation, n...
Guidelines recommend MRI as part of the staging work-up of patients with rectal cancer because it ca...
Objective and Background: Watch-and-wait approach in rectal cancer relies on the identification of a...
Background: Response to neoadjuvant chemoradiotherapy (CRT) of rectal cancer is variable. Accurate i...
To determine retrospectively the additional value of DWI-MRI toT2-MRI for predicting complete respon...
Background:The National Accreditation Program for Rectal Cancer recommends a pelvic MRI to assess th...
BACKGROUND: The response to chemoradiotherapy (CRT) for rectal cancer can be assessed by clinical ex...
AbstractBackgroundRectal cancer is one of the most common tumors in industrialized countries and one...
The assessment of tumor response, after neoadjuvant radiochemotherapy (nCRT), allows stratifying the...